Surgery Websites
Transplant Surgery »  Meet the Team »  Endocrinology »  Umesh Masharani, M.B., M.D.
Umesh Masharani, M.B., M.D.

Umesh Masharani, M.B., M.D.

  • Clinical Professor of Medicine
  • Division of Endocrinology
  • Department of Medicine

Contact Information

Endocrinology/Metabolism
400 Parnassus Ave.
ACC 585, Box 1222
San Francisco, CA 94143
umeshm@medicine.ucsf.edu

All Clinic Information

Open Popup

Middlesex Medical School, London 1982

  • Birmingham Teaching Hospital, United Kingdom, Internal Medicine 1985
  • UCSF Medical Center, Endocrinology/Metabolism 1993
  • American Board of Internal Medicine - Primary Certificate
  • American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism - Subspecialty
  • Diabetes Center
  • UCSF Kidney Transplant Program
  • Adrenal Insufficiency
  • Cushings Disease
  • Pheochromocytoma
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Diabetes Mellitus, Type 1
  • Diabetes Mellitus, Type 2
  • Hypoglycemic Agents
  • Polymorphism, Genetic
  • Polymorphism, Restriction Fragment Length

Dr. Masharani is a Clinical Professor of Endocrinology and Metabolism in the Department of Medicine, UCSF. He has an active clinical practice treating patients with diabetes and other endocrine disorders. . As a member of the UCSF Islet Transplant Group, Dr Masharani assists in managing diabetes of patients admitted to UCSF for islet transplantation evaluation.

Dr. Masharani is Co-Chair of the University of California, San Francisco Diabetes Teaching Center Annual Patient Symposium. Dr. Masharani is the author of Diabetes Demystified, a complete guide to understanding and managing diabetes.

Dr. Masharani is a Co-Investigator on a number of NIH funded diabetes studies at UCSF. His research includes studies evaluating the effect of chromium and alpha lipoic acid on insulin resistance, and anti-CD3 antibodies on new onset type 1 diabetes and multi-ethnic studies addressing the interactive relationships among disease management, glucose control and depression in patients with type 2 diabetes.

Data provided by UCSF Profiles, powered by CTSI
  • Chromium and Insulin Resistance
    Sponsor:
    Sponsor ID:
    Funding Period:
    Aug 2005
    -
    Jul 2010
    Principal Investigator
  • PEDIATRIC CLINICAL RESEARCH CENTER
    Sponsor:
    Sponsor ID:
    Funding Period:
    Dec 1981
    -
    Mar 2007
    Co-Investigator
  • BIOGENESIS, TOPOLOGY AND FUNCTION OF GRP 94
    Sponsor:
    Sponsor ID:
    Funding Period:
    Jan 1993
    -
    Jan 0001
    Principal Investigator
Data provided by UCSF Profiles, powered by CTSI
MOST RECENT PUBLICATIONS FROM A TOTAL OF 79
Data provided by UCSF Profiles, powered by CTSI
  1. Quandt Z, Kim S, Villanueva-Meyer J, Coupe C, Young A, Kang JH, Yazdany J, Schmajuk G, Rush S, Ziv E, Perdigoto AL, Herold K, Lechner MG, Su MA, Tyrrell JB, Bluestone J, Anderson M, Masharani U. Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis. J Endocr Soc. 2023 Feb 09; 7(4):bvad012. View in PubMed
  2. Huang J, Yeung AM, DuBord AY, Wolpert H, Jacobs PG, Lee WA, Drincic A, Spanakis EK, Sherr JL, Prahalad P, Fleming A, Hsiao VC, Kompala T, Lal RA, Fayfman M, Ginsberg BH, Galindo RJ, Stuhr A, Chase JG, Najafi B, Masharani U, Seley JJ, Klonoff DC. Diabetes Technology Meeting 2022. J Diabetes Sci Technol. 2023 Jan 26; 19322968221148743. View in PubMed
  3. Huang J, Yeung AM, Nguyen KT, Xu NY, Preiser JC, Rushakoff RJ, Seley JJ, Umpierrez GE, Wallia A, Drincic AT, Gianchandani R, Lansang MC, Masharani U, Mathioudakis N, Pasquel FJ, Schmidt S, Shah VN, Spanakis EK, Stuhr A, Treiber GM, Klonoff DC. Hospital Diabetes Meeting 2022. J Diabetes Sci Technol. 2022 09; 16(5):1309-1337. View in PubMed
  4. Xu NY, Nguyen KT, DuBord AY, Pickup J, Sherr JL, Teymourian H, Cengiz E, Ginsberg BH, Cobelli C, Ahn D, Bellazzi R, Bequette BW, Gandrud Pickett L, Parks L, Spanakis EK, Masharani U, Akturk HK, Melish JS, Kim S, Kang GE, Klonoff DC. Diabetes Technology Meeting 2021. J Diabetes Sci Technol. 2022 07; 16(4):1016-1056. View in PubMed
  5. Klonoff DC, Wang J, Rodbard D, Kohn MA, Li C, Liepmann D, Kerr D, Ahn D, Peters AL, Umpierrez GE, Seley JJ, Xu NY, Nguyen KT, Simonson G, Agus MSD, Al-Sofiani ME, Armaiz-Pena G, Bailey TS, Basu A, Battelino T, Bekele SY, Benhamou PY, Bequette BW, Blevins T, Breton MD, Castle JR, Chase JG, Chen KY, Choudhary P, Clements MA, Close KL, Cook CB, Danne T, Doyle FJ, Drincic A, Dungan KM, Edelman SV, Ejskjaer N, Espinoza JC, Fleming GA, Forlenza GP, Freckmann G, Galindo RJ, Gomez AM, Gutow HA, Heinemann L, Hirsch IB, Hoang TD, Hovorka R, Jendle JH, Ji L, Joshi SR, Joubert M, Koliwad SK, Lal RA, Lansang MC, Lee WA, Leelarathna L, Leiter LA, Lind M, Litchman ML, Mader JK, Mahoney KM, Mankovsky B, Masharani U, Mathioudakis NN, Mayorov A, Messler J, Miller JD, Mohan V, Nichols JH, N?rgaard K, O'Neal DN, Pasquel FJ, Philis-Tsimikas A, Pieber T, Phillip M, Polonsky WH, Pop-Busui R, Rayman G, Rhee EJ, Russell SJ, Shah VN, Sherr JL, Sode K, Spanakis EK, Wake DJ, Waki K, Wallia A, Weinberg ME, Wolpert H, Wright EE, Zilbermint M, Kovatchev B. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings. J Diabetes Sci Technol. 2022 Mar 29; 19322968221085273. View in PubMed
  6. View All Publications

 

Site Directory
    X